Narjust Florez, MD, FASCO ✓

@NarjustFlorezMD · Boston, MA · joined 21 Apr 2017

Thoracic Medical Oncologist @DanaFarberNews & @Harvardmed | Young Lung Cancer | Editor @Jamaonc | Co-founder @LatinasInMed | Personal views only.

25 472Followers

2 050Following

24 829Posts total

6.4KViews on collected posts

Son gönderiler

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD5 Sep

He knows! 725 views · 4 likes · 0 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

@NarjustFlorezMD @StephenVLiu @IASLC Skincare and fried chicken! What's not to like? 762 views · 3 likes · 0 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Are you going to #WCLC26? You MUST listen to this episode of Lung Cancer Considered https://t.co/xdjLPACb7Q @StephenVLiu @IASLC https://t.co/7PtDCfMzqf 759 views · 16 likes · 0 reposts · 1 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Are you ready for #WCLC26? In this episode of Lung Cancer Considered we tell you all you need to know - from packing to your return home. @StephenVLiu @IASLC https://t.co/xdjLPACb7Q 798 views · 8 likes · 5 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD4 Sep

Before You Go: A Practical Guide to WCLC 2026 in Seoul EVERYTHING YOU NEED TO KNOW BEFORE #WCLC26 New episode of lung cancer considered @StephenVLiu https://t.co/xdjLPACb7Q 807 views · 10 likes · 2 reposts · 0 replies Open on X →

Narjust Florez, MD, FASCO ✓@NarjustFlorezMD2 Jun

RET fusion–positive NSCLC just got its adjuvant targeted therapy LIBRETTO-432 is published in NEJM and the data are practice-changing. 🎯 Watch our clinical perspective below #ASCO26 Full publication: https://t.co/6YOeUhFO3n @RETpositive @YoungLungCancer @OncogeneCancer https: 2.5K views · 24 likes · 6 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. takipçi aralığının tam medyanında.

Medyan görüntülenme762bu hesap92410K–100K için medyan

Erişim, %2.99%bu hesap3.62%10K–100K için medyan

Etkileşim, %1.49%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	762	924	0.82×
Erişim (görüntülenme ÷ takipçi)	2.99%	3.62%	0.83×
Etkileşim oranı	1.49%	1.52%	0.98×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.5K2 Jun

8074 Sep

798

759

762

7255 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.24%2 Jun

1.49%4 Sep

1.63%

2.24%

0.52%

0.55%5 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes78.3%65 in total

Reposts15.7%13 in total

Replies2.4%2 in total

Quotes1.2%1 in total

Bookmarks2.4%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar